The use of endovascular coronary brachytherapy to prevent restenosis following percutaneous transluminal coronary angioplasty (PTCA) began in April 1997 at the Department of Interventional Cardiology of the Thoraxcenter at the University Hospital of Rotterdam. This article reviews the more than 250 patients that have been treated so far.
Department of Radiotherapy, Daniel den Hoed Cancer Center, University Hospital of Rotterdam, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands. coen@rtdh.azr.nl